GlassScriptPrepare for your visit
Mohammad S Husain
Neurology (Psychiatry & Neurology) · Valley Stream, NY · NPI 1689609141
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$16,757.64
in general payments reported to CMS, 2019-2025 · $3,549 in 2025
The $3,549 reported for 2025 was more than what 81% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Eisai INC. $2,323.01
- Sk Life Science, INC. $1,859.91
- Abbvie INC. $1,729.54
- Ucb, INC. $1,152.10
- Biogen, INC. $660.15
- Novartis Pharmaceuticals Corporation $604.23
Drugs and devices associated with these payments
Qulipta Briumvi Briviact Ubrelvy Xcopri Leqembi Vyvgart Valtoco Nurtec Odt Zeposia Ocrevus Zunovo Botox
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mohammad Husain listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/120984/mohammad-s-husain